Sporadic inclusion body myositis—diagnosis, pathogenesis and therapeutic strategies
Open Access
- 1 August 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Neurology
- Vol. 2 (8), 437-447
- https://doi.org/10.1038/ncpneuro0261
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Aggresomes and Autophagy Generate Sites for Virus ReplicationScience, 2006
- Mechanisms of Disease: signaling pathways and immunobiology of inflammatory myopathiesNature Clinical Practice Rheumatology, 2006
- Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genesBrain, 2005
- Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA‐DR3Tissue Antigens, 2004
- Direct Evidence for a Chronic CD8+-T-Cell-Mediated Immune Reaction to Tax within the Muscle of a Human T-Cell Leukemia/Lymphoma Virus Type 1-Infected Patient with Sporadic Inclusion Body MyositisJournal of Virology, 2004
- Therapeutic Approaches in Patients with Inflammatory MyopathiesSeminars in Neurology, 2003
- Molecular Analysis of T Cell Clonotypes in Muscle‐Infiltrating Lymphocytes from Patients with Human T Lymphotropic Virus Type 1 PolymyositisThe Journal of Infectious Diseases, 2002
- Inclusion body myositis and paraproteinemia: Incidence and immunopathologic correlationsAnnals of Neurology, 1997
- Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis.JCI Insight, 1996
- Common variable immunodeficiency and inclusion body myositis: A distinct myopathy mediated by natural killer cellsAnnals of Neurology, 1995